Patent Applications published on Apr 11, 2024 - page 3

#601
US20240115415A1
Human necessities

TONGUE RING AND OTHER TONGUE-ATTACHED DEVICES FOR PREVENTION OF SLEEP APNEA

#602
US20240115416A1
Human necessities

SEGMENTED EVA INTRAVAGINAL RINGS

#603
US20240115417A1
Human necessities

METHOD FOR PROVIDING THERMAL CONTRAST THERAPY

#604
US20240115418A1
Human necessities

DEVICE, SYSTEM AND METHOD OF REMOVING HEAT FROM SUBCUTANEOUS LIPID-RICH CELLS

#605
US20240115419A1
Human necessities

HEATING DEVICE

#606
US20240115420A1
Human necessities

SELECTIVELY MOVEABLE VALVE ELEMENTS FOR ASPIRATION AND IRRIGATION CIRCUITS

#607
US20240115421A1
Human necessities

REDUCING INTRAOCULAR PRESSURE (IOP) FLUCTUATIONS DURING PHACOEMULSIFICATION

#608
US20240115422A1
Human necessities

PHACOEMULSIFICATION PROBE STROKE LENGTH MAXIMIZATION SYSTEM

#609 ✅ Patent 11,992,440 granted on 2024-05-28
US20240115423A1
Human necessities

Spatial light modulation targeting of therapeutic lasers for treatment of ophthalmological conditions

#610
US20240115424A1
Human necessities

SLEEP MASK PRODUCTS

#611
US20240115425A1
Human necessities

EAR COVERING DEVICE

#612 ✅ Patent 12,138,139 granted on 2024-11-12
US20240115426A1
Human necessities

Puncture wound dressing insertion process

#613
US20240115427A1
Human necessities

REINFORCED FIBER WEB AND WOUND DRESSING MATERIAL INCLUDING THE SAME

#614
US20240115428A1
Human necessities

Period Pad Device

#615
US20240115429A1
Human necessities

ABSORBENT ARTICLE

#616
US20240115430A1
Human necessities

ABSORBENT ARTICLE HAVING WAIST GASKETING ELEMENT

#617
US20240115431A1
Human necessities

WASHABLE OUTER SHELL WITH HOOK COVER MEMBER

#618 ✅ Patent 12,207,997 granted on 2025-01-28
US20240115432A1
Human necessities

Nonwoven fabric, use of same, and method for producing nonwoven fabric

#619
US20240115433A1
Human necessities

HYDROPHILIC NONWOVEN HAVING APERTURES AND ABSORBENT ARTICLE COMPRISNG THE SAME

#620
US20240115434A1
Human necessities

ABSORBENT BODY WITH COMPOSITE ISOLATION SHEET

#621
US20240115435A1
Human necessities

ABSORBENT BODY WITH COMPOSITE ISOLATION SHEET

#622
US20240115436A1
Human necessities

FEMININE HYGIENE PAD WITH FOAM ABSORBENT AND RESERVOIR SPACER LAYER

#623
US20240115437A1
Human necessities

ABSORBENT ARTICLE COMPRISING A FRAGRANCE AND AN ODOR CONTROL COMPOSITION

#624
US20240115438A1
Human necessities

MEDICAL SUPPLY DISPENSER FOR AMBULANCE UE

#625 ✅ Patent 12,167,981 granted on 2024-12-17
US20240115439A1
Human necessities

Patient transport apparatus with adjustable handle

#626 ✅ Patent 12,226,351 granted on 2025-02-18
US20240115440A1
Human necessities

Hydraulic circuit for a patient handling apparatus

#627 ✅ Patent 12,005,007 granted on 2024-06-11
US20240115441A1
Human necessities

Wheelchair for preventing secondary transmission of germs

#628
US20240115442A1
Human necessities

PUMP-ACTION WHEELCHAIR AND CONVERSION KIT

#629 ✅ Patent 12,239,591 granted on 2025-03-04
US20240115443A1
Human necessities

Techniques for managing patient therapy protocols

#630 ✅ Patent 12,303,442 granted on 2025-05-20
US20240115444A1
Human necessities

Patient support apparatus including a user module generating state indicators corresponding to monitored conditions and changes thereof

#631
US20240115445A1
Human necessities

PATIENT WEIGHT SENSING ON AN OPERATING TABLE

#632
US20240115446A1
Human necessities

BED FALL PREVENTION DEVICE AND SYSTEM

#633 ✅ Patent 12,178,771 granted on 2024-12-31
US20240115447A1
Human necessities

Memory foam pads for lift swings and slings

#634
US20240115448A1
Human necessities

HYGIENIC BARRIER

#635 ✅ Patent 12,251,342 granted on 2025-03-18
US20240115449A1
Human necessities

Medical products storage device including access control

#636
US20240115450A1
Human necessities

OUTFLOW COLLECTION VESSELS, SYSTEMS, AND COMPONENTS THEREOF FOR HYSTEROSCOPIC SURGICAL PROCEDURES

#637
US20240115451A1
Human necessities

Prone Mat Device and Methods

#638
US20240115452A1
Human necessities

WIRELESS REMOTE ASSEMBLY AND METHOD FOR MEDICAL CHAIR

#639
US20240115453A1
Human necessities

CASKET FOR SELECTIVELY VIEWING THE DECEASED

#640
US20240115454A1
Human necessities

WEARABLE ROBOT, SYSTEM AND METHOD FOR CORRECTING GAIT IMPAIRMENTS

#641
US20240115455A1
Human necessities

SAFETY CONTROL FOR MOBILITY DEVICE

#642 ✅ Patent 12,090,109 granted on 2024-09-17
US20240115456A1
Human necessities

Vibration apparatus and massage device comprising vibration apparatus

#643
US20240115457A1
Human necessities

HEALTH CARE DEVICE AND HEALTH CARE METHOD

#644
US20240115458A1
Human necessities

Coupling Apparatus

#645
US20240115459A1
Human necessities

HYDROTHERAPY SOAKING CHAIR AND METHOD FOR USE

#646
US20240115460A1
Human necessities

SYSTEM AND METHOD FOR STIMULATING AND APPLYING PRESSURE TO POINTS ON A HUMAN BODY

#647
US20240115461A1
Human necessities

TUBE GLASS, PRIMARY PACKAGING CONTAINER FOR PHARMACEUTICAL PREPARATIONS, AND ALKALI SILICATE GLASS

#648
US20240115462A1
Human necessities

HIGH-THROUGHPUT AUTOMATED RECONSTITUTION OF LYOPHILIZED DRUG PRODUCT

#649
US20240115463A1
Human necessities

SUSTAINED RELEASE DRUG DELIVERY SYSTEMS WITH REDUCED IMPURITIES AND RELATED METHODS

#650 ✅ Patent 12,161,604 granted on 2024-12-10
US20240115464A1
Human necessities

Quick release connection for patient tube assembly

#651
US20240115465A1
Human necessities

SYSTEM AND METHOD FOR PLACEMENT VERIFICATION OF NASOGASTRIC TUBE

#652
US20240115466A1
Human necessities

PROCESS FOR PREPARING A SHAMPOO FROM AN ANHYDROUS SOLID SURFACTANT COMPOSITION

#653
US20240115467A1
Human necessities

COSMETIC PREPARATION

#654
US20240115468A1
Human necessities

COMPOSITION FOR TEETH DESENSITIZATION

#655
US20240115469A1
Human necessities

COMPOSITION FOR KERATIN FIBERS

#656
US20240115470A1
Human necessities

METHYL-FLUORO-HYDROXYBENZOATES IN CONSUMER PRODUCTS

#657
US20240115471A1
Human necessities

NON-STICKY SMOOTH STABLE COMPOSITION

#658
US20240115472A1
Human necessities

PROCESS FOR DYEING KERATIN FIBRES WITH A COMPOSITION COMPRISING A PARTICULAR OXIDATION DYE PRECURSOR, A PARTICULAR CARBOXYLIC ACID AND A CHEMICAL OXIDIZING AGENT

#659
US20240115473A1
Human necessities

HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION

#660
US20240115474A1
Human necessities

AGENTS FOR OXIDATIVELY CHANGING THE COLOR OF KERATIN FIBERS, COMPRISING A COMPLEXING AGENT, AN ACTIVATOR, AND AN OXIDANT

#661
US20240115475A1
Human necessities

KERATIN FIBERS SHAPING TOOL, AND ASSOCIATED KITS AND METHOD

#662
US20240115476A1
Human necessities

COMPOSITIONS COMPRISING A MULTI-TAIL SURFACTANT AND A CATIONIC POLYMER AND USES

#663 ✅ Patent 12,239,728 granted on 2025-03-04
US20240115477A1
Human necessities

Cosmetic composition for a matte foundation

#664
US20240115478A1
Human necessities

SUNSCREEN OR DAILY CARE COMPOSITION COMPRISING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND INORGANIC UV FILTERS

#665 ✅ Patent 12,290,586 granted on 2025-05-06
US20240115479A1
Human necessities

Cosmetic composition comprising a combination of two particular couplers and at least one oxidation base

#666
US20240115480A1
Human necessities

PROCESS FOR COATING KERATIN MATERIALS

#667 ✅ Patent 12,329,841 granted on 2025-06-17
US20240115481A1
Human necessities

FRAGRANCE RELEASE MECHANISM, METHOD AND USES THEREOF

#668
US20240115482A1
Human necessities

FORMULATION FOR THE CARE OF DAMAGED HAIR

#669
US20240115483A1
Human necessities

COMBINATION OF MODIFIED STARCH/C13-C15 FATTY ACID/CLAY WITH AMPHOTERIC SURFACTANT

#670
US20240115484A1
Human necessities

COMPOSITION COMPRISING POLYMER HYALURONIC ACID NANOPARTICLES

#671
US20240115485A1
Human necessities

NAIL COMPOSITION CONTAINING DISPERSION OF ACRYLIC POLYMER PARTICLES

#672
US20240115486A1
Human necessities

COSMETIC COMPOSITION COMPRISING AN AMINO SILICONE, A NON-AMINO SILICONE AND A NON-IONIC ASSOCIATIVE POLYMER, AND COSMETIC TREATMENT PROCESS

#673
US20240115487A1
Human necessities

Water-resistant and/or photoprotective Compositions Comprising Non-Solubilized Micronized Waxes

#674
US20240115488A1
Human necessities

COMPOSITION FOR ORAL CAVITY CARE

#675
US20240115489A1
Human necessities

PLANT EXTRACTS TO REDUCE THE APPEARANCE OF HYPERPIGMENTED SKIN OR TO LIGHTEN SKIN

#676
US20240115490A1
Human necessities

DRUG DELIVERY SYSTEM FOR ULTRA-LOW DOSE ESTROGEN COMBINATIONS AND METHODS AND USES THEREOF

#677
US20240115491A1
Human necessities

HIGH CONCENTRATION PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST FOR OPHTHALMIC DELIVERY

#678
US20240115492A1
Human necessities

AN ORODISPERSIBLE PHARMACEUTICAL SOLID DOSAGE FORM OF RASAGILINE

#679
US20240115493A1
Human necessities

SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR NEUROTROPHIC AND NEUROPROTECTIVE COMPOSITIONS

#680
US20240115494A1
Human necessities

ENCAPSULATED COMPOSITIONS AND METHOD OF USE - AFFECTING SATIETY

#681
US20240115495A1
Human necessities

FORMULATIONS AND METHODS FOR PULMONARY DELIVERY OF ACTIVE PHARMACEUTICAL INGREDIENTS

#682
US20240115496A1
Human necessities

A COMPOUND DRY POWDER INHALANT AND USE THEREOF

#683
US20240115497A1
Human necessities

INHALABLE PHARMACEUTICAL POWDER FORMULATION AND PREPARATION METHOD THEREFOR

#684
US20240115498A1
Human necessities

LIPID HYDROGEL, PREPARATION METHOD AND USE THEREOF

#685
US20240115499A1
Human necessities

DHA and Choline Emulsion

#686
US20240115500A1
Human necessities

POLYMERIC MICELLE COMPLEXES OF MRNA OR ZWITTERIONIC AGENTS, AND FORMULATIONS AND USES THEREOF

#687
US20240115501A1
Human necessities

LIPID FORMULATIONS WITH RNA ENCODING IMMUNOGENS

#688
US20240115502A1
Human necessities

LIPOSOMES AND ITS USE FOR ENZYME DELIVERY

#689
US20240115503A1
Human necessities

INTRAVESICAL DELIVERY OF HYDROPHILIC THERAPEUTIC AGENTS USING LIPOSOMES

#690
US20240115504A1
Human necessities

NANOCOMPLEX, PREPARATION METHOD THEREFOR, AND USE THEREOF

#691
US20240115505A1
Human necessities

DEVICE AND METHOD FOR FORMING SPHERICAL PARTICLE CLUSTERS WITH ULTRAFINE POWDERS

#692
US20240115506A1
Human necessities

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#693 ✅ Patent 11,964,056 granted on 2024-04-23
US20240115507A1
Human necessities

Tamper resistant dosage forms

#694 ✅ Patent 12,178,920 granted on 2024-12-31
US20240115508A1
Human necessities

Nanocrystals, compositions, and methods that aid particle transport in mucus

#695
US20240115509A1
Human necessities

A PROBIOTIC GRANULE HAVING A UNIFIED STABILIZING COATING AND A METHOD FOR THE PRODUCTION THEREOF

#696
US20240115510A1
Human necessities

TESTIS-TARGETED LYCOPENE (LYC)/ZIF-90 NANOCOMPOSITE AND PREPARATION METHOD AND USE THEREOF

#697
US20240115511A1
Human necessities

NANOMATERIALS COMPRISING AN IONIZABLE LIPID

#698
US20240115512A1
Human necessities

PROCESS FOR PREPARING NANOFORMULATION FOR DELIVERY OF BERBAMINE

#699
US20240115513A1
Human necessities

METHODS FOR PREPARATION OF PLASMID DNA/LIPID PARTICLES WITH DEFINED SIZE FOR IN VITRO AND IN VIVO TRANSFECTION

#700
US20240115514A1
Human necessities

Macrophage Targeted Immunotherapeutics

#701
US20240115515A1
Human necessities

LIVER-SPECIFIC DRUG DELIVERY CARRIER COMPRISING NUCLEIC ACID NANOPARTICLE AND CHOLESTEROL AND USE THEREOF

#702
US20240115516A1
Human necessities

TRANSDERMAL DELIVERY OF PRAMIPEXOLE AND RASAGILINE

#703
US20240115517A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVING SKIN BARRIER

#704
US20240115518A1
Human necessities

CINNAMALDEHYDE DERIVATIVE COMPOUNDS AND METHODS OF USE FOR CINNAMALDEHYDE DERIVATIVE COMPOUNDS NICOTINE CESSATION

#705 ✅ Patent 12,220,388 granted on 2025-02-11
US20240115519A1
Human necessities

Uses of curcuminoid compositions

#706 ✅ Patent 11,957,644 granted on 2024-04-16
US20240115520A1
Human necessities

Therapeutic preparation of activated St. john's Wort

#707
US20240115521A1
Human necessities

COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL DISEASES

#708
US20240115522A1
Human necessities

PHARMACEUTICAL COMPOSITIONS CONTAINING PARACETAMOL DERIVATIVES AND USE THEREOF

#709 ✅ Patent 12,156,855 granted on 2024-12-03
US20240115523A1
Human necessities

Infusion dosage form of norepinephrine

#710 ✅ Patent 12,364,674 granted on 2025-07-22
US20240115524A1
Human necessities

COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS

#711
US20240115525A1
Human necessities

ENDOXIFEN FOR THE TREATMENT OF BIPOLAR I DISORDER

#712
US20240115526A1
Human necessities

COMPOSITIONS AND METHODS COMPRISING SANSHOOL AS LIP INTERACTING COMPONENTS

#713
US20240115527A1
Human necessities

CXCR1/CXCR2 INHIBITORS FOR USE IN TREATING MYELOFIBROSIS

#714
US20240115528A1
Human necessities

COMPOSITION FOR EXTERNAL APPLICATION

#715 ✅ Patent 12,324,794 granted on 2025-06-10
US20240115529A1
Human necessities

METHOD TO ALLEVIATE THE SYMPTOMS OF PMS

#716
US20240115530A1
Human necessities

ADMINISTRATION OF BAIBA TO INCREASE BENEFIT OF LOSING WEIGHT OF INTERMITTENT FASTING

#717
US20240115531A1
Human necessities

Composition for Treating Hair and Scalp

#718
US20240115532A1
Human necessities

USE OF L-ERGOTHIONEINE FOR ALLEVIATING AND PREVENTING AGE-RELATED VISUAL DEGENERATION

#719
US20240115533A1
Human necessities

USE OF N-ACETYLCYSTEINE TO TREAT CNS DISORDERS

#720
US20240115534A1
Human necessities

COMPOSITION FOR MUSCLE ENHANCEMENT AND USE OF SAME

#721
US20240115535A1
Human necessities

Methods for Inhibiting the Progression of Neurodegenerative Diseases

#722
US20240115536A1
Human necessities

DUAL-ACTING PHARMACEUTICAL COMPOSITIONS BASED ON SUPERSTRUCTURES OF ANGIOTENSIN RECEPTOR ANTAGONIST/BLOCKER (ARB) AND NEUTRAL ENDOPEPTIDASE (NEP) INHIBITOR

#723
US20240115537A1
Human necessities

COMPOSITION FOR PREVENTING OR TREATING BREAST CANCER COMPRISING COMPOUND DERIVED FROM DENDROPANAX MORBIFERUS

#724 ✅ Patent 12,350,250 granted on 2025-07-08
US20240115538A1
Human necessities

AGGRELYTES FOR TREATING OCULAR CONDITIONS

#725
US20240115539A1
Human necessities

ENANTIOMER SELECTIVE ACTION ON NEUROTRANSMISSION

#726
US20240115540A1
Human necessities

METHODS FOR PROVIDING HEALTH BENEFITS IN ANIMALS

#727
US20240115541A1
Human necessities

METHOD FOR TREATING CEREBRAL APOPLEXY AND HYPERBILIRUBINEMIA BY COMPOUND FOR INHIBITING COMBINATION OF BILIRUBIN AND TRPM2 CHANNEL

#728
US20240115542A1
Human necessities

METHODS OF TREATING AND PREVENTING ENDOTHELIAL DYSFUNCTION USING BARDOXOLONE METHYL OR ANALOGS THEREOF

#729
US20240115543A1
Human necessities

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

#730 ✅ Patent 12,090,136 granted on 2024-09-17
US20240115544A1
Human necessities

Apparatus for treating Benign Prostatic Hyperplasia

#731
US20240115545A1
Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING B-LAPACHONE AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CHOLESTATIC LIVER DISEASE

#732
US20240115546A1
Human necessities

AGENT FOR PREVENTING OR AMELIORATING PRURITUS

#733
US20240115547A1
Human necessities

PSYCHOTROPIC AGENTS AND USES THEREOF

#734 ✅ Patent 12,357,611 granted on 2025-07-15
US20240115548A1
Human necessities

SULCARDINE ADMINISTRATION FOR TREATMENT OF ACUTE ATRIAL FIBRILLATION

#735
US20240115549A1
Human necessities

TREATMENT OF MENTAL DISORDERS

#736
US20240115550A1
Human necessities

TREATMENT OF MENTAL DISORDERS

#737
US20240115551A1
Human necessities

FORMULATIONS

#738
US20240115552A1
Human necessities

MEBENDAZOLE POLYMORPH FOR TREATMENT AND PREVENTION OF TUMORS

#739
US20240115553A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY

#740
US20240115554A1
Human necessities

METHODS FOR TREATING OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

#741
US20240115555A1
Human necessities

METHODS OF TREATING CANCER USING B-RAF INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS

#742
US20240115556A1
Human necessities

A JMJD6 TARGETING AGENT FOR TREATING PROSTATE CANCER

#743
US20240115557A1
Human necessities

INHIBITORS OF RNA-GUIDED NUCLEASES AND USES THEREOF

#744
US20240115558A1
Human necessities

ARIMOCLOMOL FOR THE TREATMENT OF NIEMANN PICK DISEASE, TYPE C, IN PATIENTS WITH ER TYPE MISSENSE MUTATIONS

#745
US20240115559A1
Human necessities

Methods and Compositions to Inhibit Symptoms Associated with Viral Upper Respiratory Tract Infections

#746
US20240115560A1
Human necessities

SYNERGISTIC MULTIMODAL OPIOID FREE ANALGESIC FORMULATION AND METHODS FOR REDUCED POSTOPERATIVE NAUSEA AND VOMITING, INFLAMMATION, AND ENHANCED POSTOPERATIVE PAIN RELIEF

#747
US20240115561A1
Human necessities

SYNERGISTIC MULTIMODAL OPIOID FREE ANALGESIC FORMULATION AND METHODS FOR REDUCED POSTOPERATIVE NAUSEA AND VOMITING, INFLAMMATION, AND ENHANCED POSTOPERATIVE PAIN RELIEF

#748
US20240115562A1
Human necessities

HIGH PENETRATION PRODRUG COMPOSITIONS AND PHARMACEUTICAL COMPOSITION THEREOF FOR TREATMENT OF PULMONARY CONDITIONS

#749 ✅ Patent 12,285,427 granted on 2025-04-29
US20240115563A1
Human necessities

Treatment of a senescence-associated ocular disease or disorder using a Bcl-xL selective inhibitor

#750
US20240115564A1
Human necessities

HTR1F ANTAGONISTS FOR IMPROVEMENT OF BETA CELL SURVIVAL AND FUNCTION

#751 ✅ Patent 12,280,048 granted on 2025-04-22
US20240115565A1
Human necessities

Amorphous solid dispersions

#752
US20240115566A1
Human necessities

METHODS OF TREATING DISORDERS ASSOCIATED WITH CASTOR

#753
US20240115567A1
Human necessities

SMALL THERAPEUTIC MOLECULES CAPABLE OF INHIBITING THE CATALYTIC ACTIVITY OF THE MAIN PROTEASE ENZYME OF SARS-COV-2

#754
US20240115568A1
Human necessities

Methods of Administering Myosin Inhibitors

#755
US20240115569A1
Human necessities

METHODS FOR BLOCKING HER2 SIGNALING FOR TREATING PULMONARY FIBROSIS

#756
US20240115570A1
Human necessities

ANTI-VIRAL AGENT

#757
US20240115571A1
Human necessities

COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH

#758
US20240115572A1
Human necessities

METHODS FOR TREATING GLIOBLASTOMAS WITH SEPIAPTERIN

#759
US20240115573A1
Human necessities

Managing the Acute and Long-Term Effects of Coronaviral Infections and Compositions Related Thereto

#760
US20240115574A1
Human necessities

INHIBITION OF nSMase FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION

#761
US20240115575A1
Human necessities

PHARMACEUTICAL COMPOSITION OF MULTI-TARGET PROTEIN KINASE INHIBITORS, AND USE THEREOF

#762
US20240115576A1
Human necessities

Caffeine Compositions

#763
US20240115577A1
Human necessities

SMALL MOLECULE REGULATORS OF ALVEOLAR TYPE 2 CELL PROLIFERATION FOR THE TREATMENT OF PULMONARY DISEASES

#764
US20240115578A1
Human necessities

DRUG COMPOSITION FOR TREATING PEDIATRIC CANCERS

#765
US20240115579A1
Human necessities

PHARMACEUTICAL COMPOSITIONS AND MANUFACTURING METHODS THEREOF

#766
US20240115580A1
Human necessities

METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS

#767
US20240115581A1
Human necessities

Combination therapy for the treatment or prevention of neurological disorders

#768
US20240115582A1
Human necessities

USE OF SODIUM TRANS-[TETRACHLORIDOBIS(1H-INDAZOLE)RUTHENATE(III)] FOR TREATING CANCERS

#769
US20240115583A1
Human necessities

COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS

#770
US20240115584A1
Human necessities

NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES

#771
US20240115585A1
Human necessities

METHODS OF TREATING CANCER

#772
US20240115586A1
Human necessities

THERAPEUTIC AGENT FOR PULMONARY FIBROSIS

#773
US20240115587A1
Human necessities

COMBINATION THERAPIES

#774
US20240115588A1
Human necessities

USE OF PROTEASOME INHIBITORS IN THE TREATMENT OF CORONAVIRUS INFECTIONS

#775
US20240115589A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING CYTOKINE STORM

#776
US20240115590A1
Human necessities

COMPOSITIONS AND THERAPEUTIC METHODS FOR TREATING CHRONIC SEQUALAE FOLLOWING VIRAL INFECTIONS

#777
US20240115591A1
Human necessities

THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING BILIARY TRACT CANCER USING DEVIMISTAT

#778
US20240115592A1
Human necessities

PGC-1alpha EXPRESSION PROMOTING AGENT, MUSCLE-BUILDING AGENT AND MITOCHONDRIA ACTIVATING AGENT

#779
US20240115593A1
Human necessities

METHISOPRINOL COMPOSITIONS

#780
US20240115594A1
Human necessities

DINUCLEOTIDES AND THEIR USE IN TREATING CANCER

#781
US20240115595A1
Human necessities

MATERIAL COMPOSITIONS AND METHODS OF USE IMPROVING RNA STABILITY

#782
US20240115596A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING SARS-COV-2 INFECTION

#783
US20240115597A1
Human necessities

METHOD FOR TREATING AND/OR PREVENTING HEARING LOSS BY USING TOLL-LIKE RECEPTOR 7 AND/OR 9 ANTAGONIST

#784
US20240115598A1
Human necessities

Methods for Treatment of Alport Syndrome

#785
US20240115599A1
Human necessities

SODIUM CHLORITE COMPOSITIONS WITH ENHANCED ANTI-MICROBIAL EFFICACY AND REDUCED TOXICITY

#786
US20240115600A1
Human necessities

ORAL GRANULES WITH COMBINATION OF EXTENDED-RELEASE AND QUICK-RELEASE MAGNESIUM, AND PRODUCTION METHODS

#787
US20240115601A1
Human necessities

NOVEL THERAPEUTIC PRODUCTS AND ITS METHOD OF PREPARATION

#788
US20240115602A1
Human necessities

ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF

#789
US20240115603A1
Human necessities

Modified Extracellular Domain of Granulocyte Colony-Stimulating Factor Receptor (G-CSFG) and Cytokines Binding Same

#790
US20240115604A1
Human necessities

METHODS OF MANUFACTURING GENETICALLY-MODIFIED LYMPHOCYTES

#791
US20240115605A1
Human necessities

CHIMERIC ANTIGEN RECEPTORS TARGETING CD20

#792
US20240115606A1
Human necessities

Cell-Based Therapeutics Targeting CD70

#793
US20240115607A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR (CAR) CONSTRUCTS AND NK CELLS EXPRESSING CAR CONSTRUCTS

#794
US20240115608A1
Human necessities

IMMUNE RECEPTORS WITH SYNTHETIC CO-STIMULATORY DOMAINS

#795
US20240115609A1
Human necessities

METHODS FOR EXPANDING AND ACTIVATING yo T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES

#796
US20240115610A1
Human necessities

GENETICALLY ENGINEERED DIAGNOSTIC CELLS AND ANTIGEN TESTS

#797
US20240115611A1
Human necessities

CHIMERIC ANTIGEN AND T CELL RECEPTORS AND METHODS OF USE

#798
US20240115612A1
Human necessities

ARTICLES OF MANUFACTURE AND METHODS FOR TREATMENT USING ADOPTIVE CELL THERAPY

#799
US20240115613A1
Human necessities

COMPOSITION FOR PREVENTION OR TREATMENT OF KIDNEY DISEASE

#800
US20240115614A1
Human necessities

STEM CELL IN WHICH IMMUNE CELL TOLERANCE MODULATOR IS OVEREXPRESSED, AND USE THEREOF

#801
US20240115615A1
Human necessities

MODIFIED STEM CELL COMPOSITIONS AND METHODS FOR USE

#802
US20240115616A1
Human necessities

METHOD FOR TREATING LIVER CIRRHOSIS BY USING COMPOSITION COMPRISING MESENCHYMAL STEM CELL, EXTRACELLULAR VESICLE PRODUCED BY MESENCHYMAL STEM CELL, AND GROWTH FACTOR

#803
US20240115617A1
Human necessities

CELLULAR COMPOSITIONS DERIVED FROM PRIOR ORGAN DONORS AND METHODS OF MANUFACTURE AND USE THEREOF

#804
US20240115618A1
Human necessities

TREATMENT OF DISEASES OF ENDOTHELIAL DYSFUNCTION AND INFLAMMATION

#805
US20240115619A1
Human necessities

TREATMENT OF DIABETES BY ENHANCEMENT OF PANCREATIC ISLET ENGRAFTMENT THROUGH REGENERATIVE IMMUNE MODULATION

#806
US20240115620A1
Human necessities

PREPARATION AND THERAPEUTIC USE OF 3D-CULTURED FIBROBLASTS

#807 ✅ Patent 12,357,660 granted on 2025-07-15
US20240115621A1
Human necessities

XENOGRAFT SOFT TISSUE IMPLANTS AND METHODS OF MAKING

#808
US20240115622A1
Human necessities

FORMULATION FOR THE PREVENTION AND/OR TREATMENT OF COVID-19

#809
US20240115623A1
Human necessities

METHOD OF EXPANDING A COMPLEX COMMUNITY OF MICROORGANISMS

#810
US20240115624A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF INFLAMMATORY SKIN DISEASES COMPRISING RUMINOCOCCUS GNAVUS AS ACTIVE INGREDIENT

#811
US20240115625A1
Human necessities

ROSEBURIA HOMINIS, EUBACTERIUM ELIGENS, AND COMBINATIONS THEREOF AS BIOTHERAPEUTICS

#812
US20240115626A1
Human necessities

COMPOSITIONS AND METHODS TO INCREASE PRODUCTION OF ISOTHIOCYANATES

#813
US20240115627A1
Human necessities

USE OF CLOSTRIDIUM GHONII SPORE COMBINED WITH PEMBROLIZUMAB

#814
US20240115628A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING FIBROSIS COMPRISING LEUCONOSTOC CITREUM STRAIN AS ACTIVE INGREDIENT

#815
US20240115629A1
Human necessities

ORAL COMPOSITION

#816
US20240115630A1
Human necessities

BIFIDOBACTERIA FOR REDUCING FOOD, ENERGY AND/OR FAT INTAKE

#817
US20240115631A1
Human necessities

COMPOSITION COMPRISING GRAIN-DERIVED LACTIC ACID BACTERIA FOR RELIEVING HANGOVER AND BOWEL TROUBLE

#818
US20240115632A1
Human necessities

COMPOSITION COMPRISING LACTOBACILLUS PLANTARUM-DERIVED POLYSACCHARIDE OR EXTRACT

#819
US20240115633A1
Human necessities

COMPOSITION FOR THE NUTRITION OR DRINK OF A NON-HUMAN ANIMAL

#820
US20240115634A1
Human necessities

COMPOSITION FOR SUPPRESSING DETERIORATION OF OR ENHANCING MEMORY LEARNING FUNCTION AND/OR COGNITIVE FUNCTION

#821 ✅ Patent 12,251,410 granted on 2025-03-18
US20240115635A1
Human necessities

Anticancer trail-targeted plant virus particles

#822
US20240115636A1
Human necessities

ENCAPSULATED RNA POLYNUCLEOTIDES AND METHODS OF USE

#823
US20240115637A1
Human necessities

INFLAMMATION AND PAIN REDUCING THERAPEUTIC COMPOSITION

#824
US20240115638A1
Human necessities

APPARATUS, SYSTEM AND METHODS FOR PROCESSING OF HARVESTED CANNABIS PLANT MATERIAL

#825
US20240115639A1
Human necessities

OIL EXTRACT OF CANNABIS AND METHOD FOR OBTAINING

#826
US20240115640A1
Human necessities

METHOD FOR PREPARING GINSENG EXTRACT ENRICHED WITH RARE GINSENOSIDES AND APPLICATIONS THEREOF

#827
US20240115641A1
Human necessities

ORAL FILM AND STICK JELLY FOR IMPROVING ABSORPTION IN THE ORAL MUCOSA, ANTIOXIDANT ACTIVITY, ANTI-INFLAMMATORY ACTIVITY, AND LIVER FUNCTION OF HUMANS AND COMPANION ANIMALS

#828
US20240115642A1
Human necessities

Composition for preventing hair loss or promoting hair growth comprising milk thistle flower extract as an active ingredient

#829
US20240115643A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN CONDITIONS

#830
US20240115644A1
Human necessities

COMPOSITION FOR PREVENTING, IMPROVING OR TREATING GASTRITIS OR PEPTIC ULCER COMPRISING EXTRACT OF CINNAMOMUM CASSIA, FRACTION OF SAID EXTRACT, ISOLATE OF SAID FRACTION OR COMPOUNDS ISOLATED THEREFROM

#831
US20240115645A1
Human necessities

DRUG FOR TREATING UROLITHIASIS-RELATED DISEASE, AND PREPARATION METHOD THEREFOR

#832
US20240115646A1
Human necessities

Nutritional Supplement

#833
US20240115647A1
Human necessities

COMPOSITION COMPRISING FLAVANOL MONOMERS AND E-VINIFERIN

#834 ✅ Patent 12,257,281 granted on 2025-03-25
US20240115648A1
Human necessities

Hydrophilic antibody-drug conjugates

#835
US20240115649A1
Human necessities

CASPASE INHIBITION TO ENHANCE REGENERATION AND REPAIR AFTER SKIN OR GUT INJURY AND TO TREAT BACTERIAL OR VIRAL INFECTIONS

#836
US20240115650A1
Human necessities

Methods for Treating HCV

#837
US20240115651A1
Human necessities

PEPTIDES FOR TREATING DISEASE AND REDUCING SYMPTOMS RELATED TO MULTIPLE SCLEROSIS

#838
US20240115652A1
Human necessities

TISSUE OCCLUDING AGENT COMPRISING AN IEIKIEIKIEIKI PEPTIDE

#839
US20240115653A1
Human necessities

METHODS OF INHIBITING INTEGRIN ALPHA9BETA1 ACTIVITY

#840
US20240115654A1
Human necessities

INTRAVENOUS ADMINISTRATION OF ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES

#841 ✅ Patent 12,290,566 granted on 2025-05-06
US20240115655A1
Human necessities

Dosing regimens and related compositions and methods

#842
US20240115656A1
Human necessities

Treatment of Constipation-Predominant Irritable Bowel Syndrome

#843
US20240115657A1
Human necessities

COMPOSITION COMPRISING OIL DROPS

#844
US20240115658A1
Human necessities

Use of an intervertebral disc fibrosis-inducing substance in preparation of medication

#845
US20240115659A1
Human necessities

VIRAL TREATMENT

#846
US20240115660A1
Human necessities

SOLUBLE TREM2 PROTEIN AND USES THEREOF

#847
US20240115661A1
Human necessities

METHODS OF TREATING METABOLIC DISORDERS WITH FGF21 VARIANTS

#848
US20240115662A1
Human necessities

METHODS OF TREATING HYPOGONADOTROPIC HYPOGONADISM AND COGNITION IMPAIRMENT FOLLOWING A TRAUMATIC BRAIN INJURY

#849
US20240115663A1
Human necessities

COMPOSITIONS COMPRISING AT LEAST AN INSULIN AND AN AMYLIN RECEPTOR AGONIST FOR TREATING DIABETES, IN A PATIENT/PERSON HAVING A BMI OF MORE THAN 28 KG/M² AND/OR AN HBA1C OF MORE THAN 7.6%

#850
US20240115664A1
Human necessities

Diketopiperazine Salts for Drug Delivery and Related Methods

#851
US20240115665A1
Human necessities

USE OF LOW VOLUME PLASMA EXCHANGE FOR TREATING THE EARLY AND MIDDLE STAGES OF ALZHEIMER'S DISEASE

#852
US20240115666A1
Human necessities

COMPOSITIONS AND METHODS FOR REDUCING GAMMA-GLUTAMYLTRANSFERASE LEVELS

#853
US20240115667A1
Human necessities

DIPHENHYDRAMINE AND LACTOFERRIN FOR PREVENTION AND TREATMENT OF COVID-19

#854
US20240115668A1
Human necessities

TREATMENT OF SPINAL CORD INJURY WITH PTEN INHIBITOR

#855
US20240115669A1
Human necessities

METHODS FOR REDUCING PATHOGENIC E COLI BY SELECTIVE FEED ADDITIVE INTERVENTION COMPRISING ENZYMES SUCH AS MURAMIDASE

#856
US20240115670A1
Human necessities

FIBROBLAST ACTIVATION PROTEIN MODULATION TO ALTER IMMUNE CELL MIGRATION AND TUMOR INFILTRATION

#857
US20240115671A1
Human necessities

INTRACELLULAR DELIVERY OF THERAPEUTIC PROTEINS DESIGNED TO INVADE AND AUTONOMOUSLY LYSE AND METHODS OF USE THEREOF

#858
US20240115672A1
Human necessities

TREATMENT OF AN IOP CONDITION

#859
US20240115673A1
Human necessities

METHOD AND COMPOSITION FOR THE TREATMENT OF CANCER

#860
US20240115674A1
Human necessities

VACCINE AND METHODS FOR PREVENTING FILARIASIS AND DIROFILARIASIS

#861
US20240115675A1
Human necessities

METHOD OF TREATING A TUMOR WITH A COMBINATION OF AN IL-7 PROTEIN AND A NUCLEOTIDE VACCINE

#862
US20240115676A1
Human necessities

SILICIFIED TUMOR CELL COMPOSITIONS AND METHODS

#863 ✅ Patent 12,357,678 granted on 2025-07-15
US20240115677A1
Human necessities

Cancer Stem Cell Targeted Cancer Vaccines

#864
US20240115678A1
Human necessities

PERSONALIZED MULTIDISCIPLINARY CANCER THERAPY

#865 ✅ Patent 12,324,843 granted on 2025-06-10
US20240115679A1
Human necessities

COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS

#866
US20240115680A1
Human necessities

Optimized Synthetic Consensus Immunogenic Compositions Targeting the Follicle Stimulating Hormone Receptor (FSHR)

#867
US20240115681A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING TOLL-LIKE RECEPTOR AGONIST AND STIMULATOR OF INTERFERON GENES AGONIST AND USE THEREOF

#868
US20240115682A1
Human necessities

METHODS OF TREATING CANCER USING HETEROARYL-BIPHENYL AMIDE DERIVATIVES

#869 ✅ Patent 12,358,976 granted on 2025-07-15
US20240115683A1
Human necessities

EFFECTIVE AND EFFICIENT CONTROL OF SERUM PHOSPHATE FOR OPTIMAL BONE FORMATION

#870
US20240115684A1
Human necessities

CANCER THERAPY

#871
US20240115685A1
Human necessities

CONJUGATED FUMONISIN TO PROTECT AGAINST MYCOTOXICOSIS

#872
US20240115686A1
Human necessities

SHIGELLA MULTI-EPITOPE FUSION ANTIGEN PROTEINS AND METHODS OF USE

#873 ✅ Patent 11,992,522 granted on 2024-05-28
US20240115687A1
Human necessities

Attenuating bacterial virulence by attenuating bacterial folate transport

#874
US20240115688A1
Human necessities

Novel Antigens

#875
US20240115689A1
Human necessities

VACCINES AGAINST ZIKA VIRUS

#876
US20240115690A1
Human necessities

MDCK SUSPENSION CELL LINES IN SERUM-FREE, CHEMICALLY-DEFINED MEDIA FOR VACCINE PRODUCTION

#877 ✅ Patent 12,220,455 granted on 2025-02-11
US20240115691A1
Human necessities

Coronavirus vaccine compositions and methods

#878
US20240115692A1
Human necessities

COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES

#879
US20240115693A1
Human necessities

SARS-COV-2 ANTIGEN NANOPARTICLES AND USES THERE OF

#880
US20240115694A1
Human necessities

HBV VACCINE

#881
US20240115695A1
Human necessities

Method of Obtaining Betulin as an Adjuvant in a Vaccine Against Coronavirus SARS-COV-2

#882
US20240115696A1
Human necessities

ANTIBODIES TO TIGIT

#883 ✅ Patent 12,337,034 granted on 2025-06-24
US20240115697A1
Human necessities

HUMANIZED CC CHEMOKINE RECEPTOR 4 (CCR4) ANTIBODIES AND METHODS OF USE THEREOF

#884
US20240115698A1
Human necessities

ANTI-IL-5 ANTIBODY FORMULATION, PREPARATION METHOD THEREFOR AND USE THEREOF

#885
US20240115699A1
Human necessities

USE OF CANCER CELL EXPRESSION OF CADHERIN 12 AND CADHERIN 18 TO TREAT MUSCLE INVASIVE AND METASTATIC BLADDER CANCERS

#886
US20240115700A1
Human necessities

CANCER TREATMENT COMBINATIONS

#887
US20240115701A1
Human necessities

METHODS AND COMPOSITIONS COMPRISING AN ANTI-CTLA4 MONOCLONAL ANTIBODY WITH REDUCED HOST CELL PROTEINS AND INCREASED POLYSORBATE-80 STABILITY

#888
US20240115702A1
Human necessities

HIGH CONCENTRATION PROTEIN FORMULATIONS WITH REDUCED VISCOSITY

#889
US20240115703A1
Human necessities

GENETICALLY ENGINEERED ANTI-CD19 CAR-T CELLS FOR USE IN TREATING B-CELL MALIGNANCIES

#890
US20240115704A1
Human necessities

TREATMENT OF CANCER WITH NK CELLS AND A CD38-TARGETED ANTIBODY

#891
US20240115705A1
Human necessities

Regulation of Butyrophilin subfamily 3 member A1 (BTN3A1, CD277)

#892
US20240115706A1
Human necessities

GUCY2C BINDING POLYPEPTIDE AND USES THEREOF

#893
US20240115707A1
Human necessities

DNA REPAIR COMPOSITION

#894
US20240115708A1
Human necessities

Dosing Regimens For The Treatment Of Fabry Disease

#895
US20240115709A1
Human necessities

ASSEMBLY OF ORGANIC SUPRAMOLECULAR VESSELS FOR CONTROLLED DRUG RELEASE

#896
US20240115710A1
Human necessities

SYNTHESIS ROUTES TO ACCESS MDMA PRODRUGS BY USING CONTROLLED AND NON-CONTROLLED INTERMEDIATES

#897
US20240115711A1
Human necessities

Novel Bifunctional Molecules For Targeted Protein Degradation

#898
US20240115712A1
Human necessities

SEMICARBAZONE-BASED SAPONIN CONJUGATE

#899
US20240115713A1
Human necessities

POLYETHYLENE GLYCOL CONJUGATE DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#900
US20240115714A1
Human necessities

GLYCAN MODIFIED NUCLEIC ACIDS, METHODS OF PREPARATION, AND THERAPEUTIC USES